OptiBiotix Health Plc (AIM: OPTI)
London
· Delayed Price · Currency is GBP · Price in GBX19.29
+1.42 (7.92%)
Sep 11, 2024, 3:45 PM GMT+1
OptiBiotix Health Statistics
Total Valuation
OptiBiotix Health has a market cap or net worth of GBP 17.51 million. The enterprise value is 16.87 million.
| Market Cap | 17.51M |
| Enterprise Value | 16.87M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiBiotix Health has 97.94 million shares outstanding. The number of shares has decreased by -3.24% in one year.
| Shares Outstanding | 97.94M |
| Shares Change (YoY) | -3.24% |
| Shares Change (QoQ) | +4.33% |
| Owned by Insiders (%) | 11.27% |
| Owned by Institutions (%) | 4.81% |
| Float | 86.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.04 |
| PB Ratio | 1.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.27 |
| EV / Sales | 26.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.67
| Current Ratio | 7.67 |
| Quick Ratio | 6.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.62% and return on invested capital (ROIC) is -10.71%.
| Return on Equity (ROE) | -20.62% |
| Return on Assets (ROA) | -10.11% |
| Return on Capital (ROIC) | -10.71% |
| Revenue Per Employee | 64,400 |
| Profits Per Employee | -203,900 |
| Employee Count | 10 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.35% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.35% |
| 50-Day Moving Average | 23.23 |
| 200-Day Moving Average | 22.36 |
| Relative Strength Index (RSI) | 36.22 |
| Average Volume (20 Days) | 276,931 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OptiBiotix Health had revenue of GBP 644,000 and -2.04 million in losses. Loss per share was -0.02.
| Revenue | 644,000 |
| Gross Profit | 320,000 |
| Operating Income | -1.70M |
| Pretax Income | -2.04M |
| Net Income | -2.04M |
| EBITDA | -1.49M |
| EBIT | -1.70M |
| Loss Per Share | -0.02 |
Balance Sheet
| Cash & Cash Equivalents | 635,000 |
| Total Debt | n/a |
| Net Cash | 635,000 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 8.87M |
| Book Value Per Share | 0.10 |
| Working Capital | 1.20M |
Cash Flow
| Operating Cash Flow | -1.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 49.69% |
| Operating Margin | -263.20% |
| Pretax Margin | -317.24% |
| Profit Margin | n/a |
| EBITDA Margin | -231.37% |
| EBIT Margin | -263.20% |
| FCF Margin | n/a |
Dividends & Yields
OptiBiotix Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.24% |
| Shareholder Yield | 3.24% |
| Earnings Yield | -12.65% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |